Yes, they do. Glaxo better start bidding now because the Bakers may just use GHDX to purchase DDXS. It would be the perfect addition to their diagnostic portfolio. $10 is closer than you think. And there are many connections between GHDX and DDXS. Ward is from GHDX. Bakers own 45% GHDX and 13% DDXS. Both diagnostic pharms. I'm not selling under 10 because this is worth 20-30 longterm.